Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]

Advances in CLL treatment

Prof Peter Hillmen - St James’s University Hospital, Leeds, UK

Advances in CLL treatment ( Prof Peter Hillmen - St James’s University Hospital, Leeds, UK )

Latest advances in multiple myeloma

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands

Latest advances in multiple myeloma ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )

Patient advocacy session on treatment adherence

Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK

Patient advocacy session on treatment adherence ( Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK )

Key CLL research from EHA 2011

Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain

Key CLL research from EHA 2011 ( Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain )

Dasatinib therapy for CML patients unsuitable for imatinib

Prof Giuseppe Saglio - University of Turin, Italy

Dasatinib therapy for CML patients unsuitable for imatinib ( Prof Giuseppe Saglio - University of Turin, Italy )

VTD consolidation therapy for multiple myeloma

Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy

VTD consolidation therapy for multiple myeloma ( Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy )

Patient non-compliance to treatment schedules

Giora Sharf - Israeli CML Patient's Support Group

Patient non-compliance to treatment schedules ( Giora Sharf - Israeli CML Patient's Support Group )

ASCO 2011 highlights

Prof Gordon McVie – ecancer Managing Editor

ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )

Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy

Dr Paul Richardson - Dana Farber Institute, Boston, USA

Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy ( Dr Paul Richardson - Dana Farber Institute, Boston, USA )

Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology

Prof Robin Foà - Sapienza University of Rome, Italy

Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology ( Prof Robin Foà - Sapienza University of Rome, Italy )

Role of maintenance therapy in multiple myeloma

Prof Gareth Morgan, Prof Antonio Palumbo and Dr Paul Richardson

Role of maintenance therapy in multiple myeloma ( Prof Gareth Morgan, Prof Antonio Palumbo and Dr Paul Richardson )

Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma

Prof Jesús San Miguel - University Hospital of Salamanca, Spain

Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma ( Prof Jesús San Miguel - University Hospital of Salamanca, Spain )

More from ecancer